Control of scaffold degradation in tissue engineering: a review.

Tissue engineering has shown a great promise as a solution to the high demand for tissue and organ transplantations. Biomaterial scaffolds serve to house and direct cells to grow, exposing them to an adequate perfusion of nutrients, oxygen, metabolic products, and appropriate growth factors to enhance their differentiation and function. The degradation of biomaterial scaffolds is a key factor to successful tissue regeneration. In this article, the existing degradation control approaches in the context of scaffold tissue engineering were reviewed and a new paradigm of thinking called active control of scaffold degradation, proposed elsewhere by us, was also revisited and discussed in light of its benefit and requirement of this new technology.

[1]  H. M. Byrne,et al.  The interplay between tissue growth and scaffold degradation in engineered tissue constructs , 2012, Journal of Mathematical Biology.

[2]  Ramille N Shah,et al.  Three-dimensional printing of soy protein scaffolds for tissue regeneration. , 2013, Tissue engineering. Part C, Methods.

[3]  Mika Salmi,et al.  Novel additive manufactured scaffolds for tissue engineered trachea research , 2013, Acta oto-laryngologica.

[4]  H. Zreiqat,et al.  Porous scaffolds with tailored reactivity modulate in-vitro osteoblast responses. , 2012, Materials science & engineering. C, Materials for biological applications.

[5]  Fang Yang,et al.  Biocompatibility and degradation characteristics of PLGA-based electrospun nanofibrous scaffolds with nanoapatite incorporation. , 2012, Biomaterials.

[6]  R. Cameron,et al.  Synthetic collagen fascicles for the regeneration of tendon tissue. , 2012, Acta biomaterialia.

[7]  Hua Liu,et al.  Controllable structure, properties, and degradation of the electrospun PLGA/PLA‐blended nanofibrous scaffolds , 2012 .

[8]  J. Kenny,et al.  Plasma surface modification of porous PLLA films: Analysis of surface properties and in vitro hydrolytic degradation , 2012 .

[9]  Bone marrow mesenchymal stem cells increase skin regeneration efficiency in skin and soft tissue expansion , 2012, Expert opinion on biological therapy.

[10]  M. Bizzarri,et al.  A new approach for the preparation of hydrophilic poly(L‐lactide) porous scaffold for tissue engineering by using lamellar single crystals , 2012 .

[11]  A. Macková,et al.  Nanostructuring of polymethylpentene by plasma and heat treatment for improved biocompatibility , 2012 .

[12]  Y. Nho,et al.  Degradation behavior of poly (l-lactide-co-glycolide) films through gamma-ray irradiation , 2012 .

[13]  Scott J Hollister,et al.  Strut size and surface area effects on long-term in vivo degradation in computer designed poly(L-lactic acid) three-dimensional porous scaffolds. , 2012, Acta biomaterialia.

[14]  D. Poulikakos,et al.  Direct printing of nanostructures by electrostatic autofocussing of ink nanodroplets , 2012, Nature Communications.

[15]  Wim E Hennink,et al.  In vivo biocompatibility and biodegradation of 3D-printed porous scaffolds based on a hydroxyl-functionalized poly(ε-caprolactone). , 2012, Biomaterials.

[16]  M. Spagnuolo,et al.  Fabrication and Degradation of Electrospun Scaffolds from L-Tyrosine-Based Polyurethane Blends for Tissue Engineering Applications , 2012 .

[17]  V. Meda,et al.  Synthesis, characterization and comparison of antimicrobial activity of PEG/TritonX-100 capped silver nanoparticles on collagen scaffold. , 2012, Colloids and surfaces. B, Biointerfaces.

[18]  John L Ricci,et al.  Three-Dimensional Printing of Bone Repair and Replacement Materials: Impact on Craniofacial Surgery , 2012, The Journal of craniofacial surgery.

[19]  J. Jansen,et al.  In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres. , 2011, Acta biomaterialia.

[20]  Hirenkumar K. Makadia,et al.  Poly Lactic-co-Glycolic Acid ( PLGA ) as Biodegradable Controlled Drug Delivery Carrier , 2011 .

[21]  A Ranella,et al.  Direct laser writing of 3D scaffolds for neural tissue engineering applications , 2011, Biofabrication.

[22]  D. Farrar,et al.  Through-thickness control of polymer bioresorption via electron beam irradiation. , 2011, Acta biomaterialia.

[23]  Scott Broderick,et al.  Identifying factors controlling protein release from combinatorial biomaterial libraries via hybrid data mining methods. , 2011, ACS combinatorial science.

[24]  S. Lade,et al.  Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity , 2010, Haematologica.

[25]  Q. Fu,et al.  Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. I. Preparation and in vitro degradation. , 2010, Journal of biomedical materials research. Part A.

[26]  Yubo Fan,et al.  Influences of tensile load on in vitro degradation of an electrospun poly(L-lactide-co-glycolide) scaffold. , 2010, Acta biomaterialia.

[27]  Paolo Zunino,et al.  A mixture model for water uptake, degradation, erosion and drug release from polydisperse polymeric networks. , 2010, Biomaterials.

[28]  A. Heise,et al.  Autocatalytic equation describing the change in molecular weight during hydrolytic degradation of aliphatic polyesters. , 2010, Biomacromolecules.

[29]  B. Narasimhan,et al.  Novel, high throughput method to study in vitro protein release from polymer nanospheres. , 2010, Journal of combinatorial chemistry.

[30]  Shulamit Levenberg,et al.  Cell-scaffold mechanical interplay within engineered tissue. , 2009, Seminars in cell & developmental biology.

[31]  GeunHyung Kim,et al.  Three-Dimensional Plotter Technology for Fabricating Polymeric Scaffolds with Micro-grooved Surfaces , 2009, Journal of biomaterials science. Polymer edition.

[32]  N. Peppas,et al.  Modeling of drug release from biodegradable polymer blends. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[33]  Casey K. Chan,et al.  Degradation of electrospun nanofiber scaffold by short wave length ultraviolet radiation treatment and its potential applications in tissue engineering. , 2008, Tissue engineering. Part A.

[34]  J. Kenny,et al.  Effects of carbon nanotubes (CNTs) on the processing and in-vitro degradation of poly(dl-lactide-co-glycolide)/CNT films , 2008, Journal of materials science. Materials in medicine.

[35]  A. Albertsson,et al.  Degradation Products of Aliphatic and Aliphatic-Aromatic Polyesters , 2008 .

[36]  Diane J Burgess,et al.  Effect of acidic pH on PLGA microsphere degradation and release. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[37]  Suping Lyu,et al.  Kinetics and time-temperature equivalence of polymer degradation. , 2007, Biomacromolecules.

[38]  M. Walton,et al.  Long-term in vivo Degradation of Poly-L-lactide (PLLA) in Bone , 2007, Journal of biomaterials applications.

[39]  Shaobing Zhou,et al.  Investigation of drug release and matrix degradation of electrospun poly(DL-lactide) fibers with paracetanol inoculation. , 2006, Biomacromolecules.

[40]  Nobuhiko Yui,et al.  Electrospun PLGA nanofiber scaffolds for articular cartilage reconstruction: mechanical stability, degradation and cellular responses under mechanical stimulation in vitro , 2006, Journal of biomaterials science. Polymer edition.

[41]  E. Entcheva,et al.  Electrospun fine-textured scaffolds for heart tissue constructs. , 2005, Biomaterials.

[42]  O. Kwon,et al.  A composite of hydroxyapatite with electrospun biodegradable nanofibers as a tissue engineering material. , 2005, Journal of bioscience and bioengineering.

[43]  P. Sikorski,et al.  Development and application of a model for chitosan hydrolysis by a family 18 chitinase , 2005, Biopolymers.

[44]  J. Loo,et al.  Degradation of poly(lactide-co-glycolide) (PLGA) and poly(L-lactide) (PLLA) by electron beam radiation. , 2005, Biomaterials.

[45]  Anne Simmons,et al.  Long-term in vivo biostability of poly(dimethylsiloxane)/poly(hexamethylene oxide) mixed macrodiol-based polyurethane elastomers. , 2004, Biomaterials.

[46]  J. Dutta,et al.  Chitin and chitosan: Chemistry, properties and applications , 2004 .

[47]  R. Chen,et al.  Effect of degree of deacetylation of chitosan on the kinetics of ultrasonic degradation of chitosan , 2003 .

[48]  A. Göpferich,et al.  Why degradable polymers undergo surface erosion or bulk erosion. , 2002, Biomaterials.

[49]  P. Bianco,et al.  Stem cells in tissue engineering , 2001, Nature.

[50]  S. Withers,et al.  Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate , 2001, Nature.

[51]  J. Siepmann,et al.  Mathematical modeling of bioerodible, polymeric drug delivery systems. , 2001, Advanced drug delivery reviews.

[52]  U A Stock,et al.  Tissue engineering: current state and prospects. , 2001, Annual review of medicine.

[53]  J. Davies,et al.  In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam. , 1999, Biomaterials.

[54]  Jeffrey A. Hubbell,et al.  Polymeric biomaterials with degradation sites for proteases involved in cell migration , 1999 .

[55]  Suming Li,et al.  Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. , 1999 .

[56]  S. Brocchini,et al.  The study of water uptake in degradable polymers by thermally stimulated depolarization currents. , 1998, Biomaterials.

[57]  A. Goepferich,et al.  An Approach to Classify Degradable Polymers , 1998 .

[58]  O. Smidsrod,et al.  In vitro degradation rates of partially N-acetylated chitosans in human serum. , 1997, Carbohydrate research.

[59]  A. Göpferich,et al.  Bioerodible implants with programmable drug release , 1997 .

[60]  M. Matsumoto,et al.  Enzymatic hydrolysis reaction of water-soluble chitin derivatives with egg white lysozyme , 1997 .

[61]  J. Santerre,et al.  Application of macromolecular additives to reduce the hydrolytic degradation of polyurethanes by lysosomal enzymes. , 1997, Biomaterials.

[62]  A. Albertsson,et al.  Weight losses and molecular weight changes correlated with the evolution of hydroxyacids in simulated in vivo degradation of homo-and copolymers of PLA and PGA , 1996 .

[63]  K Zygourakis,et al.  Computer-aided design of bioerodible devices with optimal release characteristics: a cellular automata approach. , 1996, Biomaterials.

[64]  J. Ruijgrok,et al.  Collagen implants remain supple not allowing fibroblast ingrowth. , 1995, Biomaterials.

[65]  K. Nakahama,et al.  Human lysozyme: sequencing of a cDNA, and expression and secretion by Saccharomyces cerevisiae. , 1988, Biochemical and biophysical research communications.

[66]  K. Himmelstein,et al.  A simultaneous transport-reaction model for controlled drug delivery from catalyzed bioerodible polymer matrices , 1985 .

[67]  K. Himmelstein,et al.  Modelling of drug release kinetics from a laminated device having an erodible drug reservoir. , 1984, Biomaterials.

[68]  Robert Langer,et al.  Chemical and Physical Structure of Polymers as Carriers for Controlled Release of Bioactive Agents: A Review , 1983 .

[69]  G. Waychunas Mössbauer, EXAFS, and X-ray diffraction study of Fe3+ clusters in MgO:Fe and magnesiowüstite (Mg,Fe)1−xO-evidence for specific cluster geometries , 1983 .

[70]  H. Hopfenberg,et al.  Swelling‐controlled, constant rate delivery systems , 1978 .

[71]  M. Salton,et al.  Cell Wall of Micrococcus Lysodeikticus as the Substrate of Lysozyme , 1952, Nature.

[72]  K. M. Wiegand PLANT EMBRYO-SACS. , 1900, Science.